{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:43:03Z","timestamp":1758588183710,"version":"3.44.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.transproceed.2022.12.016","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T09:22:35Z","timestamp":1679390555000},"page":"649-653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Can Kunxian Capsule, a Novel Tripterygium Preparation be Used as an Adjuvant Treatment of Early Recurrent Focal Segmental Glomerular Sclerosis After Renal Transplantation? A Case Report"],"prefix":"10.1016","volume":"55","author":[{"given":"Rula","family":"Sa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiliang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daqiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2022.12.016_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2021.100675","article-title":"Management of recurrent focal segmental glomerulosclerosis (FSGS) post renal transplantation","volume":"36","author":"Al Shamsi","year":"2022","journal-title":"Transplant Rev"},{"key":"10.1016\/j.transproceed.2022.12.016_bib0002","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s10157-019-01690-0","article-title":"Successful management of post-transplant focal segmental glomerulosclerosis with therapeutic plasma exchange and rituximab","volume":"23","author":"Koutroutsos","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.transproceed.2022.12.016_bib0003","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s11255-020-02462-6","article-title":"Combined rituximab and plasmapheresis or plasma exchange for focal segmental glomerulosclerosis in adult kidney transplant recipients: a meta-analysis","volume":"52","author":"Hansrivijit","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.transproceed.2022.12.016_bib0004","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12882-022-02814-7","article-title":"Effectiveness and safety of KunXian capsule for the treatment of IgA nephropathy","volume":"23","author":"Le","year":"2022","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.transproceed.2022.12.016_bib0005","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal segmental glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.12.016_bib0006","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/TP.0000000000001160","article-title":"Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation","volume":"101","author":"Garrouste","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.12.016_bib0007","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.transproceed.2020.01.024","article-title":"Combination of high-dose intravenous cyclosporine and plasma exchange treatment is effective in post-transplant recurrent focal segmental glomerulosclerosis: results of case series","volume":"52","author":"Demir","year":"2020","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2022.12.016_bib0008","first-page":"405","article-title":"Tripterygium wilfordii Hook f in rheumatoid arthritis and ankylosing spondylitis. Preliminary report","volume":"94","author":"Guo","year":"1981","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.transproceed.2022.12.016_bib0009","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejmech.2019.05.032","article-title":"Triptolide: medicinal chemistry, chemical biology and clinical progress","volume":"176","author":"Hou","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.transproceed.2022.12.016_bib0010","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.abb.2019.07.012","article-title":"Triptolide preserves glomerular barrier function via the inhibition of p53-mediated increase of GADD45B","volume":"671","author":"Zhai","year":"2019","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.transproceed.2022.12.016_bib0011","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/ki.2008.203","article-title":"Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro","volume":"74","author":"Zheng","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2022.12.016_bib0012","first-page":"1","article-title":"The derivative of Tripterygium wilfordii Hook F\u2014Kunxian Capsule, attenuated rheumatoid arthritis: a systematic review and meta-analysis","volume":"2020","author":"Liu","year":"2020","journal-title":"Evid-Based Complementary Altern Med"},{"key":"10.1016\/j.transproceed.2022.12.016_bib0013","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s13063-016-1438-6","article-title":"Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial","volume":"17","author":"Li","year":"2016","journal-title":"Trials"},{"key":"10.1016\/j.transproceed.2022.12.016_bib0014","first-page":"723","article-title":"Efficacy and safety of a novel Tripterygium preparation in the treatment of refractory proteinuria in kidney transplant recipients","volume":"42","author":"Ru-La","year":"2021","journal-title":"Chin J Organ Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134523000830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134523000830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:45:44Z","timestamp":1758577544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134523000830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0041134523000830"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.12.016","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can Kunxian Capsule, a Novel Tripterygium Preparation be Used as an Adjuvant Treatment of Early Recurrent Focal Segmental Glomerular Sclerosis After Renal Transplantation? A Case Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}